AR201880A1 - Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazol - Google Patents
Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazolInfo
- Publication number
- AR201880A1 AR201880A1 AR255045A AR25504574A AR201880A1 AR 201880 A1 AR201880 A1 AR 201880A1 AR 255045 A AR255045 A AR 255045A AR 25504574 A AR25504574 A AR 25504574A AR 201880 A1 AR201880 A1 AR 201880A1
- Authority
- AR
- Argentina
- Prior art keywords
- nitrotiazol
- benzamido
- procedure
- preparation
- new derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/58—Nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3760873A GB1437800A (en) | 1973-08-08 | 1973-08-08 | Derivatives of 2-benzamido-5-nitro-thiazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR201880A1 true AR201880A1 (es) | 1975-04-24 |
Family
ID=10397712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR255045A AR201880A1 (es) | 1973-08-08 | 1974-08-05 | Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazol |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3950351A (es) |
| JP (1) | JPS5041858A (es) |
| AR (1) | AR201880A1 (es) |
| BE (1) | BE817878A (es) |
| CA (1) | CA1041519A (es) |
| CH (1) | CH583215A5 (es) |
| DE (1) | DE2438037C2 (es) |
| ES (1) | ES428906A1 (es) |
| FR (1) | FR2240010B1 (es) |
| GB (1) | GB1437800A (es) |
| IL (1) | IL45194A (es) |
| NL (1) | NL176779C (es) |
| OA (1) | OA04761A (es) |
| ZA (1) | ZA744409B (es) |
Families Citing this family (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2435905A1 (fr) * | 1978-09-13 | 1980-04-11 | Anvar | Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole |
| US4315018A (en) * | 1978-12-07 | 1982-02-09 | Rossignol Jean F | Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives |
| AR226579A1 (es) * | 1979-12-21 | 1982-07-30 | Wellcome Found | Metodo para la preparacion de un compuesto de 2-benzoilimino-5-nitro-4-tiazolin-3-acetamida |
| US5387598A (en) * | 1994-04-13 | 1995-02-07 | Rossignol; Jean-Francois | Composition and galenic formulation suitable for combatting affections of the lower abdomen |
| US5578621A (en) * | 1994-09-08 | 1996-11-26 | Romark Lab Lc | Benzamide derivatives |
| PL186504B1 (pl) * | 1994-04-13 | 2004-01-30 | Romark Lab | Pochodne benzamidowe i kompozycje farmaceutyczne zawierające te pochodne |
| US5859038A (en) * | 1994-09-08 | 1999-01-12 | Romark Laboratories, L.C. | Method for treatment of helicobacter pylori infections |
| US5968961A (en) * | 1997-05-07 | 1999-10-19 | Romark Laboratories, L.C. | Pharmaceutical compositions of tizoxanide and nitazoxanide |
| MX9604483A (es) * | 1994-09-08 | 1998-02-28 | Jean-Francois Rossignol | Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas. |
| CN100515420C (zh) * | 1997-05-07 | 2009-07-22 | 罗马克实验室有限公司 | 脱乙酰基硝噻醋柳胺和硝噻醋柳胺的药用组合物 |
| AU756451B2 (en) * | 1997-05-07 | 2003-01-16 | Romark Laboratories, L.C. | Pharmaceutical compositions of tizoxanide and nitazoxanide |
| US5935591A (en) * | 1998-01-15 | 1999-08-10 | Romark Laboratories, L.C. | Method for treatment of equine protozoal myeloencephalitis with thiazolides |
| US5925622A (en) * | 1998-07-13 | 1999-07-20 | Romark Laboratories, L.C. | Synthesis of aryl glucuronide of 2-hydroxy-N- (5-nitro-2-thiazolyl) benzamide, and pharmaceutical compositions comprising same |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| US7125568B2 (en) | 2001-08-23 | 2006-10-24 | Sung Michael T | Lipophilic drug compositions |
| GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| GB0325402D0 (en) * | 2003-10-31 | 2003-12-03 | Astrazeneca Ab | Compounds |
| GB0327761D0 (en) * | 2003-11-29 | 2003-12-31 | Astrazeneca Ab | Compounds |
| GB0328178D0 (en) * | 2003-12-05 | 2004-01-07 | Astrazeneca Ab | Compounds |
| BRPI0507746A (pt) * | 2004-02-18 | 2007-07-10 | Astrazeneca Ab | composto ou um sal, pró-droga ou solvato do mesmo, composição farmacêutica, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto |
| KR20070007104A (ko) * | 2004-02-18 | 2007-01-12 | 아스트라제네카 아베 | 화합물 |
| TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
| UA90864C2 (en) | 2004-09-09 | 2010-06-10 | Ромарк Лебораториз, Л.К. | Halogenated benzamide derivatives |
| US20060194853A1 (en) * | 2004-10-08 | 2006-08-31 | Rossignol Jean F | Alkyl benzamides |
| GB0423043D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
| KR20070085371A (ko) | 2004-10-16 | 2007-08-27 | 아스트라제네카 아베 | 페녹시 벤즈아미드 화합물의 제조 방법 |
| GB0423044D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
| AU2006235490A1 (en) * | 2005-04-12 | 2006-10-19 | Romark Laboratories, L.C. | Methods for treating diseases through the function of molecular chaperones such as protein disulfide isomerases, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
| EP1891069A1 (en) * | 2005-05-24 | 2008-02-27 | AstraZeneca AB | 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators |
| TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
| EP2027113A1 (en) * | 2005-07-09 | 2009-02-25 | AstraZeneca AB | Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| JP2009500442A (ja) * | 2005-07-09 | 2009-01-08 | アストラゼネカ アクチボラグ | ２型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての２−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物 |
| KR101346902B1 (ko) * | 2005-07-09 | 2014-01-02 | 아스트라제네카 아베 | 당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한헤테로아릴 벤즈아미드 유도체 |
| US9202182B2 (en) * | 2005-08-11 | 2015-12-01 | International Business Machines Corporation | Method and system for analyzing business architecture |
| TW200738621A (en) * | 2005-11-28 | 2007-10-16 | Astrazeneca Ab | Chemical process |
| CA2636527C (en) | 2006-01-09 | 2016-05-17 | Romark Laboratories, L.C. | Viral hepatitis treatment |
| WO2008008480A2 (en) * | 2006-07-12 | 2008-01-17 | Cumbre Pharmaceuticals Inc. | Nitroheteroaryl-containing rifamycin derivatives |
| CN100465169C (zh) * | 2006-08-02 | 2009-03-04 | 杭州欣阳三友精细化工有限公司 | 硝唑尼特的制备方法 |
| TW200825063A (en) * | 2006-10-23 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
| TW200825060A (en) * | 2006-10-26 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
| KR20090090390A (ko) * | 2006-12-21 | 2009-08-25 | 아스트라제네카 아베 | Ｇｌｋ 활성제로서 유용한 신규 결정 화합물 |
| CN101007792B (zh) * | 2007-01-31 | 2010-05-26 | 浙江大学 | 一种合成硝基噻唑苯酰胺化合物的方法 |
| ES2550755T3 (es) | 2007-08-03 | 2015-11-12 | Romark Laboratories, L.C. | Compuestos de tiazolida sustituidos con alquilsulfonilo |
| EP2324028A2 (en) * | 2008-08-04 | 2011-05-25 | AstraZeneca AB | Therapeutic agents 414 |
| RS53347B (sr) | 2008-12-09 | 2014-10-31 | Gilead Sciences, Inc. | Modulatori toll-sličnih receptora |
| GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
| SI2395840T1 (sl) | 2009-02-13 | 2020-08-31 | Romark Laboratories, L.C. | Farmacevtske formulacije nitazoksanida z nadzorovanim sproščanjem |
| GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
| AR076221A1 (es) * | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad |
| WO2010116177A1 (en) | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity |
| NZ596538A (en) | 2009-05-12 | 2014-04-30 | Romark Lab Lc | Haloalkyl heteroaryl benzamide compounds |
| CN108042535A (zh) | 2009-06-26 | 2018-05-18 | 罗马克实验室有限公司 | 用于治疗流感的化合物和方法 |
| CN101602744B (zh) * | 2009-06-30 | 2011-06-01 | 青岛康地恩药业有限公司 | 一种硝唑尼特的制备方法 |
| WO2013110975A1 (es) | 2012-01-27 | 2013-08-01 | Siegfried Rhein S.A. De C.V. | Composición de nitazoxanida mejorada y proceso para prepararla |
| WO2014049397A1 (es) | 2012-09-27 | 2014-04-03 | Siegfried Rhein S.A. De C.V. | Composición sinérgica de nitazoxanida y mebendazol, procesos para prepararla y el uso de dicha composición para el tratamiento de la parasitosis humana |
| EP3010345A4 (en) * | 2013-06-21 | 2017-04-12 | The Regents of The University of California | Expanded therapeutic potential in nitroheteroaryl antimicrobials |
| JP6522732B2 (ja) | 2014-07-11 | 2019-05-29 | ギリアード サイエンシーズ， インコーポレイテッド | Ｈｉｖを治療するためのトール様受容体の調節因子 |
| SG11201701520TA (en) | 2014-09-16 | 2017-04-27 | Gilead Sciences Inc | Solid forms of a toll-like receptor modulator |
| MX2017006083A (es) | 2014-11-11 | 2017-11-08 | Romark Laboratories Lc | Composicones y metodos de tratamiento con profarmacos de tizoxanida, un analogo o sal de la misma. |
| CN105175352A (zh) * | 2015-10-27 | 2015-12-23 | 杭州澳医保灵药业有限公司 | 一种硝唑尼特的制备方法 |
| CN106831640A (zh) * | 2015-12-03 | 2017-06-13 | 江苏正大丰海制药有限公司 | 一种硝唑尼特晶体的制备方法 |
| PT3436074T (pt) | 2016-03-31 | 2020-08-21 | Romark Laboratories Lc | Compostos tiazolida para tratamento de infeções virais |
| JP6894923B2 (ja) | 2016-04-11 | 2021-06-30 | ジェンフィＧｅｎｆｉｔ | 胆汁うっ滞性及び線維性の疾患の処置方法 |
| US11033534B2 (en) | 2017-01-27 | 2021-06-15 | Genfit | Pharmaceutical compositions for combination therapy |
| WO2018195035A1 (en) | 2017-04-18 | 2018-10-25 | Romark Laboratories L.C. | Inhibition of protein disulfide-isomerase a3 |
| WO2019241376A1 (en) | 2018-06-14 | 2019-12-19 | The Trustees Of Columbia University In The City Of New York | Treatment of cognitive disorders using nitazoxanide (ntz), nitazoxanide (ntz) analogs, and metabolites thereof |
| CA3130518A1 (en) | 2019-04-12 | 2020-10-15 | Nicolas STANKOVIC-VALENTIN | Nitazoxanide and thiazolides for use in the treatment of diseases associated with oxidative stress |
| TWI810456B (zh) | 2019-05-22 | 2023-08-01 | 美商基利科學股份有限公司 | Tlr7調節化合物及hiv疫苗之組合 |
| JP7741800B2 (ja) | 2019-10-28 | 2025-09-18 | ジェンフィット | 抗酸化性質を有する併用療法 |
| US20230303504A1 (en) | 2020-07-20 | 2023-09-28 | Romark Laboratories, L.C. | Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine |
| MX2023002208A (es) | 2020-08-24 | 2023-05-17 | Romark Laboratories Lc | Uso de tiazolidas contra los coronavirus. |
| CN114044761B (zh) * | 2021-02-24 | 2022-05-17 | 成都贝诺科成生物科技有限公司 | 一种新的硝基噻唑衍生物及其应用 |
| CN115197164B (zh) * | 2021-04-12 | 2025-04-01 | 杜心赟 | 新型噻唑类化合物及其制备方法和用途 |
| WO2023058046A1 (en) | 2021-10-05 | 2023-04-13 | Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) | An improved process for the preparation of nitazoxanide and intermediates thereof |
| WO2023198095A1 (zh) * | 2022-04-12 | 2023-10-19 | 成都贝诺科成生物科技有限公司 | 一种硝基噻唑衍生物在制备抑制幽门螺杆菌的抑菌剂中的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2829084A (en) * | 1958-04-01 | Certain alkyl-n | ||
| US2735798A (en) * | 1956-02-21 | Acyl amevo-nitrothiazole compositions | ||
| CA497537A (en) * | 1953-11-10 | H. Clark Joe | 2-substituted amino-5-nitrothiazoles | |
| GB577418A (en) * | 1942-04-17 | 1946-05-17 | Sandoz Ltd | Process for the preparation of amides of aromatic carboxylic acids |
| US2401522A (en) * | 1942-04-17 | 1946-06-04 | Firm Sandoz Ltd | Aromatic carboxylic acid amides and a process for their manufacture |
| FR1306603A (fr) * | 1958-08-14 | 1962-10-19 | Innothera Lab Sa | Dérivés thiazoliques et leur procédé de préparation |
| US3475446A (en) * | 1967-06-27 | 1969-10-28 | Parke Davis & Co | N-(5-nitro-2-thiazolyl)-cycloalkanecarboxamides |
-
1973
- 1973-08-08 GB GB3760873A patent/GB1437800A/en not_active Expired
-
1974
- 1974-07-03 IL IL45194A patent/IL45194A/en unknown
- 1974-07-09 ZA ZA00744409A patent/ZA744409B/xx unknown
- 1974-07-10 NL NLAANVRAGE7409321,A patent/NL176779C/xx not_active IP Right Cessation
- 1974-07-19 BE BE146759A patent/BE817878A/xx not_active IP Right Cessation
- 1974-07-23 CA CA205,468A patent/CA1041519A/en not_active Expired
- 1974-07-23 JP JP49083868A patent/JPS5041858A/ja active Pending
- 1974-08-02 ES ES428906A patent/ES428906A1/es not_active Expired
- 1974-08-05 AR AR255045A patent/AR201880A1/es active
- 1974-08-07 DE DE2438037A patent/DE2438037C2/de not_active Expired
- 1974-08-07 CH CH1083074A patent/CH583215A5/xx not_active IP Right Cessation
- 1974-08-08 FR FR7427525A patent/FR2240010B1/fr not_active Expired
- 1974-08-08 US US05/495,749 patent/US3950351A/en not_active Expired - Lifetime
- 1974-08-08 OA OA55271A patent/OA04761A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| OA04761A (fr) | 1980-08-31 |
| FR2240010B1 (es) | 1978-03-24 |
| IL45194A0 (en) | 1974-10-22 |
| CH583215A5 (es) | 1976-12-31 |
| JPS5041858A (es) | 1975-04-16 |
| BE817878A (fr) | 1975-01-20 |
| NL7409321A (nl) | 1975-02-11 |
| NL176779C (nl) | 1985-06-03 |
| GB1437800A (en) | 1976-06-03 |
| NL176779B (nl) | 1985-01-02 |
| IL45194A (en) | 1977-10-31 |
| AU7135574A (en) | 1976-01-22 |
| FR2240010A1 (es) | 1975-03-07 |
| ZA744409B (en) | 1975-07-30 |
| US3950351A (en) | 1976-04-13 |
| CA1041519A (en) | 1978-10-31 |
| DE2438037C2 (de) | 1982-06-09 |
| ES428906A1 (es) | 1976-08-16 |
| DE2438037A1 (de) | 1975-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR201880A1 (es) | Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazol | |
| AR207133A1 (es) | Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano | |
| MX152550A (es) | Procedimiento para la preparacion de derivados de fenilnonatetraenos substituidos | |
| AR202618A1 (es) | Procedimiento para la preparacion de metiltioalquilguanidinas heterociclicas | |
| MX4588E (es) | Procedimiento para la preparacion de i-ariloxi-2-hidroxi-3-alquinilaminopropanos | |
| AR210725A1 (es) | Procedimiento para la preparacion de derivados de dibenzoxepina | |
| MX3765E (es) | Procedimiento para la preparacion de derivados de piperidina | |
| MX5768E (es) | Procedimiento para la preparacion de derivados del alpha-etil-benzhidrol | |
| AR203188A1 (es) | Procedimiento para la preparacion de derivados de tienotriazolodiacepina | |
| AR203653A1 (es) | Procedimiento para la obtencion de derivados de 3,4-dihidro-2h-naftalinona-(1)-5-oxi-propil-piperazina | |
| AR207022A1 (es) | Procedimiento para la preparacion de poli-n-dimetiliminoalano | |
| AR207744A1 (es) | Procedimiento para la preparacion de nuevos derivados de isotiocianopiridinas | |
| AR206632A1 (es) | Procedimiento para la preparacion de d-homoesteroides | |
| AR208187A1 (es) | Metodo para la preparacion derivados de n-carbamoil-2-feniletensulfonamida | |
| AR203196A1 (es) | Procedimiento para la preparacion de derivados de imidazol-5-carboxamidoxima | |
| AR205800A1 (es) | Procedimiento para la preparacion de nuevos derivados de 3,4-difenil-imidazolina | |
| AR200441A1 (es) | Procedimiento para la obtencion de nuevos derivados de alfa-l-arabinosido de digitoxigenina | |
| AR207633Q (es) | Procedimiento para la elaboracion de nuevos derivados de 2-benzoil-3-amino-6-cloro-piridinas | |
| AR210133A1 (es) | Procedimiento para preparar nuevos derivados de 3-amino-5-metil-pirrol | |
| AR207450A1 (es) | Procedimiento para la produccion de derivados de 4-fenilsulfonil-metil-prehidroindan-5-onas | |
| AR206653A1 (es) | Procedimiento para preparar nuevos derivados de n-aminoalquil-2-amino-indano | |
| AR209616A1 (es) | Procedimiento para la preparacion de derivados de 17alpha-aciloxi-d-homo-pregn-4-eno-3,20-diona | |
| AR211695A1 (es) | Procedimiento para la preparacion de derivados de aminoscilanilidas primarias | |
| AR202848A1 (es) | Procedimiento para la preparacion de derivados de triazolobenzodiacepinas | |
| AR201032A1 (es) | Un procedimiento para la preparacion de derivados de 5-feniltienodiazepinona |